Wang-shick Ryu

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

A Randomized Trial of Nafamostat for Covid-19.

A Randomized Trial of Nafamostat for Covid-19.

Journal: NEJM evidence
Published: February 06, 2024

Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.

Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.

Journal: Journal of medical virology
Published: June 27, 2020

Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.

Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.

Journal: Antiviral research
Published: October 22, 2019

Characterization of the molecular events of covalently closed circular DNA synthesis in de novo Hepatitis B virus infection of human hepatoma cells.

Characterization of the molecular events of covalently closed circular DNA synthesis in de novo Hepatitis B virus infection of human hepatoma cells.

Journal: Antiviral research
Published: November 05, 2018

Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.

Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.

Journal: Journal of hepatology
Published: September 28, 2018

Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.

Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.

Journal: Journal of hepatology
Published: February 12, 2018

Effect of S267F variant of NTCP on the patients with chronic hepatitis B.

Effect of S267F variant of NTCP on the patients with chronic hepatitis B.

Journal: Scientific reports
Published: June 01, 2017

DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.

DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.

Journal: Journal of virology
Published: May 19, 2016

Development of a novel hepatitis B virus encapsidation detection assay by viral nucleocapsid-captured quantitative RT-PCR.

Development of a novel hepatitis B virus encapsidation detection assay by viral nucleocapsid-captured quantitative RT-PCR.

Journal: BioTechniques
Published: July 02, 2015

The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide.

The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide.

Journal: Antiviral therapy
Published: April 27, 2015

DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level.

DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level.

Journal: Journal of virology
Published: September 19, 2014

Residues Arg703, Asp777, and Arg781 of the RNase H domain of hepatitis B virus polymerase are critical for viral DNA synthesis.

Residues Arg703, Asp777, and Arg781 of the RNase H domain of hepatitis B virus polymerase are critical for viral DNA synthesis.

Journal: Journal of virology
Published: October 18, 2013
Showing 1-12 of 14

Last Updated: 09/26/2026